Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 14Uterine Cervical Neoplasms 10Fallopian Tube Neoplasms 9Carcinoma, Ovarian Epithelial 7Peritoneal Neoplasms 4Neoplasm, Residual 2Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Sarcoma 1Recurrence 1Postoperative Complications 1Neoplasms 1Locally Advanced Cervical Cancer 1Intermittent Fasting 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma 1Advanced Ovarian Cancer 1

Interventions

Saline Solution 3Carboplatin 2Bevacizumab 2talazoparib 1stenoparib 1senaparib 1sargramostim 1olaparib 1niraparib 1liposomal doxorubicin 1Tranexamic Acid 1Ropivacaine 1Paclitaxel 1Observation 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Ovarian Cancer × Neoadjuvant Therapy × Gynecologic × Clear all
NCT01462149 2017-05-31

Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer

Asan Medical Center

Phase 2 Completed
43 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡